Cite
Paris LP, Johnson CH, Aguilar E, et al. Global metabolomics reveals metabolic dysregulation in ischemic retinopathy. Metabolomics. 2015;12:15doi: 10.1007/s11306-015-0877-5.
Paris, L. P., Johnson, C. H., Aguilar, E., Usui, Y., Cho, K., Hoang, L. T., Feitelberg, D., Benton, H. P., Westenskow, P. D., Kurihara, T., Trombley, J., Tsubota, K., Ueda, S., Wakabayashi, Y., Patti, G. J., Ivanisevic, J., Siuzdak, G., & Friedlander, M. (2016). Global metabolomics reveals metabolic dysregulation in ischemic retinopathy. Metabolomics : Official journal of the Metabolomic Society, 1215. https://doi.org/10.1007/s11306-015-0877-5
Paris, Liliana P, et al. "Global metabolomics reveals metabolic dysregulation in ischemic retinopathy." Metabolomics : Official journal of the Metabolomic Society vol. 12 (2016): 15. doi: https://doi.org/10.1007/s11306-015-0877-5
Paris LP, Johnson CH, Aguilar E, Usui Y, Cho K, Hoang LT, Feitelberg D, Benton HP, Westenskow PD, Kurihara T, Trombley J, Tsubota K, Ueda S, Wakabayashi Y, Patti GJ, Ivanisevic J, Siuzdak G, Friedlander M. Global metabolomics reveals metabolic dysregulation in ischemic retinopathy. Metabolomics. 2016;12:15. doi: 10.1007/s11306-015-0877-5. Epub 2015 Nov 18. PMID: 26617478; PMCID: PMC4651979.
Copy
Download .nbib